{"id":"eptifibatide-injection","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Bleeding"},{"rate":"1-2","effect":"Thrombocytopenia"},{"rate":"5-10","effect":"Hypotension"},{"rate":"2-5","effect":"Bradycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Eptifibatide is a cyclic heptapeptide that reversibly binds to the glycoprotein IIb/IIIa receptor on platelet surfaces, inhibiting the final common pathway of platelet aggregation. By blocking fibrinogen and von Willebrand factor from cross-linking platelets, it prevents thrombus formation. This antiplatelet effect is used during percutaneous coronary intervention to reduce ischemic complications.","oneSentence":"Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks platelet aggregation by preventing fibrinogen binding to platelet receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:11:20.118Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction)"},{"name":"Percutaneous coronary intervention"}]},"trialDetails":[{"nctId":"NCT03844594","phase":"PHASE3","title":"Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2019-04-06","conditions":"Acute Ischemic Stroke","enrollment":220},{"nctId":"NCT00061373","phase":"PHASE2","title":"Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2003-05","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT00719914","phase":"PHASE2","title":"A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2007-11","conditions":"ST-Elevation Myocardial Infarction","enrollment":31},{"nctId":"NCT00945308","phase":"PHASE2","title":"Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2009-08","conditions":"Acute Myocardial Infarction","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"ANAEMIA"},{"count":4,"reaction":"HAEMOGLOBIN DECREASED"},{"count":2,"reaction":"MEDIASTINAL HAEMATOMA"},{"count":2,"reaction":"THROMBOCYTOPENIA"},{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"AREFLEXIA"},{"count":1,"reaction":"CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR"},{"count":1,"reaction":"CONDITION AGGRAVATED"},{"count":1,"reaction":"CORONARY ARTERY THROMBOSIS"},{"count":1,"reaction":"DISSEMINATED INTRAVASCULAR COAGULATION"}],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Eptifibatide Injection","genericName":"Eptifibatide Injection","companyName":"Ministry of Science and Technology of the People´s Republic of China","companyId":"ministry-of-science-and-technology-of-the-people-s-republic-of-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks platelet aggregation by preventing fibrinogen binding to platelet receptors. Used for Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction), Percutaneous coronary intervention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}